SG Americas Securities’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-73,488
Closed -$223K 3304
2024
Q4
$223K Sell
73,488
-3,475
-5% -$10.5K ﹤0.01% 1811
2024
Q3
$399K Buy
+76,963
New +$399K ﹤0.01% 1675
2024
Q1
Sell
-62,598
Closed -$550K 3093
2023
Q4
$550K Buy
+62,598
New +$550K 0.01% 1276
2023
Q2
Sell
-21,549
Closed -$694K 2953
2023
Q1
$694K Buy
21,549
+14,087
+189% +$454K 0.01% 1329
2022
Q4
$138K Sell
7,462
-3,940
-35% -$72.9K ﹤0.01% 2263
2022
Q3
$308K Buy
+11,402
New +$308K ﹤0.01% 1756
2021
Q4
Sell
-33,961
Closed -$946K 3421
2021
Q3
$946K Buy
33,961
+26,578
+360% +$740K ﹤0.01% 1800
2021
Q2
$219K Sell
7,383
-6,610
-47% -$196K ﹤0.01% 2071
2021
Q1
$391K Buy
13,993
+9,255
+195% +$259K ﹤0.01% 1985
2020
Q4
$134K Sell
4,738
-44,343
-90% -$1.25M ﹤0.01% 2544
2020
Q3
$1.23M Buy
49,081
+23,851
+95% +$600K 0.01% 870
2020
Q2
$616K Buy
25,230
+15,360
+156% +$375K 0.01% 1606
2020
Q1
$146K Buy
9,870
+1,944
+25% +$28.8K ﹤0.01% 2311
2019
Q4
$129K Buy
+7,926
New +$129K ﹤0.01% 2413
2019
Q2
Sell
-10,981
Closed -$173K 2920
2019
Q1
$173K Buy
+10,981
New +$173K ﹤0.01% 2335
2017
Q4
Sell
-5,231
Closed -$144K 3048
2017
Q3
$144K Buy
+5,231
New +$144K ﹤0.01% 2514
2017
Q1
Sell
-10,734
Closed -$222K 3042
2016
Q4
$222K Buy
+10,734
New +$222K ﹤0.01% 2011
2016
Q2
Sell
-7,351
Closed -$128K 2524
2016
Q1
$128K Buy
+7,351
New +$128K ﹤0.01% 2175
2015
Q3
Sell
-3,291
Closed -$105K 2380
2015
Q2
$105K Buy
+3,291
New +$105K ﹤0.01% 1994